AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 101 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,910,067 | -39.8% | 11,114,431 | +4.6% | 0.01% | -40.0% |
| Q2 2023 | $117,807,558 | -29.2% | 10,622,864 | -2.0% | 0.01% | +25.0% |
| Q1 2023 | $166,365,040 | +52.2% | 10,838,114 | +120.0% | 0.01% | -27.3% |
| Q4 2022 | $109,294,139 | +92.7% | 4,925,378 | +41.8% | 0.01% | +83.3% |
| Q3 2022 | $56,703,000 | +2.4% | 3,472,319 | -8.8% | 0.01% | 0.0% |
| Q2 2022 | $55,347,000 | -21.4% | 3,809,123 | -0.0% | 0.01% | 0.0% |
| Q1 2022 | $70,387,000 | -21.6% | 3,810,915 | +0.9% | 0.01% | -14.3% |
| Q4 2021 | $89,768,000 | -4.9% | 3,776,524 | -1.5% | 0.01% | 0.0% |
| Q3 2021 | $94,423,000 | +12.6% | 3,833,667 | +12.9% | 0.01% | 0.0% |
| Q2 2021 | $83,874,000 | +12.0% | 3,394,315 | -1.1% | 0.01% | +16.7% |
| Q1 2021 | $74,887,000 | -14.3% | 3,433,588 | +0.3% | 0.01% | -25.0% |
| Q4 2020 | $87,383,000 | +2.8% | 3,424,135 | +13.4% | 0.01% | -11.1% |
| Q3 2020 | $84,980,000 | +6.2% | 3,018,831 | +6.6% | 0.01% | 0.0% |
| Q2 2020 | $80,056,000 | – | 2,832,852 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |